Glomerular filtration rate is associated with burden of coronary atherosclerosis in patients with acute coronary syndrome

Angiology

Volumn 65, Issue 4, 2014, Pages 350-356

  Duran, Mustafa ^a   Uysal, Onur Kadir ^b   Gunebakmaz, Ozgur ^c   Baran, Oguzhan ^b   Turfan, Murat ^d   Ornek, Ender ^e   Cetin, Mustafa ^e   Murat, Sani Namik ^a   Yarlioglues, Mikail ^a   Karadeniz, Muhammed ^a   Kurtul, Alpaslan ^a   Kaya, Mehmet Gungor ^f  

^a Ankara Education Research Hospital   (Turkey)

^b KAYSERI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c HARRAN UNIVERSITY   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^e ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f ERCIYES UNIVERSITY   (Turkey)

Author keywords

acute coronary syndrome; Gensini score; glomerular filtration rate; SYNTAX score

Indexed keywords

CREATININE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; FEMALE; GENSINI SCORE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MILD RENAL IMPAIRMENT; MODERATE RENAL IMPAIRMENT; MULTIPLE LINEAR REGRESSION ANALYSIS; RISK FACTOR; SYNTAX SCORE;

ACUTE CORONARY SYNDROME; GENSINI SCORE; GLOMERULAR FILTRATION RATE; SYNTAX SCORE;

ACUTE CORONARY SYNDROME; ADULT; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY OCCLUSION; CORONARY STENOSIS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY DISEASES; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84895500973     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713486536     Document Type: Article

References (42)

1. Kaya MG, Uyarel H, Akpek M, et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012 ; 109 (4). 486-491
2. Akpek M, Kaya MG, Uyarel H, et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis. 2011 ; 219 (1). 334-341
3. Sahin O, Akpek M, Elcik D, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology. 2013 ; 64 (3). 200-204
4. Murat SN, Duran M, Kalay N, et al. Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes. Angiology. 2013 ; 64 (2). 131-136
5. Peralta CA, Lee A, Odden MC, et al. Association between chronic kidney disease detected using creatinine and cystatin C and death and cardiovascular events in elderly Mexican Americans: the Sacramento Area Latino Study on Aging. J Am Geriatr Soc. 2013 ; 61 (1). 90-95
6. Choi JS, Kim CS, Bae EH, et al. Predicting outcomes after myocardial infarction by using the chronic kidney disease epidemiology collaboration equation in comparison with the modification of diet in renal disease study equation: results from the Korea Acute Myocardial Infarction Registry. Nephrol Dial Transplant. 2012 ; 27 (10). 3868-3874
7. Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2011 ; 32 (14). 1769-1818
8. Ratto E, Leoncini G, Viazzi F, Pontremoli R. Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications. G Ital Nefrol. 2008 ; 25 (1). 21-31
9. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006 ; 145 (4). 237-246
10. Huang G, Zhao JL, Du H, Lan XB, Yin YH. Coronary score adds prognostic information for patients with acute coronary syntrome. Circ J. 2010 ; 74 (3). 490-495
11. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999 ; 130 (6). 461-470
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 ; 39 (2 suppl 1). S1 - S266
13. Gensini GG.. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983 ; 51 (3). 606-607
14. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention. 2009 ; 5 (1). 50-56
15. Kassirer JP.. Clinical evaluation of kidney function: Glomerular function. N Engl J Med. 1971 ; 285 (7). 385-389
16. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function. Measured and estimated glomerular filtration rate. N Engl J Med. 2006 ; 354 (23). 2473-2483
17. Pugliese G, Solini A, Bonora E, et al. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation provides a better definition of cardiovascular burden associated with CKD than the Modification of Diet in Renal Disease (MDRD) Study formula in subjects with type 2 diabetes. Atherosclerosis. 2011 ; 218 (1). 194-199
18. Hemmelgarn BR, Southern DA, Humphries KH, Culleton BF, Knudtson ML, Ghali WA. Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J. 2006 ; 27 (10). 1191-1197
19. Gibson CM, Dumaine RL, Gelfand EV, et al. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. Eur Heart J. 2004 ; 25 (22). 1998-2005
20. Fácila L, Núñez J, Bodí V, et al. Prognostic value of serum creatinine in non-ST-elevation acute coronary syndrome. Rev Esp Cardiol. 2006 ; 59 (3). 209-216
21. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999 ; 56 (6). 2214-2219
22. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology. 2006 ; 67 (2). 224-228
23. Shik J, Parfrey PS. The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens. 2005 ; 14 (6). 550-557
24. Fox CS, Larson MG, Keyes MJ, et al. Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study. Kidney Int. 2004 ; 66 (5). 2017-2021
25. Ix JH, Katz R, Kestenbaum B, et al. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol. 2008 ; 19 (3). 579-585
26. Nicholls SJ, Tuzcu EM, Hsu A, et al. Comparison of coronary atherosclerotic volume in patients with glomerular filtration rates < or = 60 versus > 60 ml/min/1.73 m(2): a meta-analysis of intravascular ultrasound studies. Am J Cardiol. 2007 ; 99 (6). 813-816
27. Abaci A, Sen N, Yazici H, et al. Renal dysfunction is the most important predictor of the extent and severity of coronary artery disease in patients with diabetes mellitus. Coron Artery Dis. 2007 ; 18 (6). 463-469
28. Nunes JP, Faria Mdo S, Garcia JM, Gonçalves FR. Glomerular filtration rate and coronary artery disease burden in patients with acute coronary syndrome. Clin Cardiol. 2007 ; 30 (9). 464-468
29. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009 ; 360 (10). 961-972
30. Van Gaal WJ, Ponnuthurai FA, Selvanayagam J, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 2009 ; 135 (1). 60-65
31. Uhlig K, Levey AS, Sarnak MJ. Traditional cardiac risk factors in individuals with chronic kidney disease. Semin Dial. 2003 ; 16 (2). 118-127
32. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 ; 25: 377
33. Madore F. Uremia-related metabolic cardiac risk factors in chronic kidney disease. Semin Dial. 2003 ; 16 (2). 148-156
34. Stam F, van Guldener C, Becker A, et al. Endothelial dysfunction contributes to renal functionassociated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006 ; 17 (2). 537-545
35. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000 ; 15 (7). 1014-1021
36. Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail. 2006 ; 12 (8). 601-607
37. Bibbins-Domingo K, Lin F, Vittinghoff E, et al. Predictors of heart failure among women with coronary disease. Circulation. 2004 ; 110 (11). 1424-1430
38. Wu Y, Wang Y, An C, et al. Effects of rosuvastatin and atorvastatin on renal function: meta-analysis. Circ J. 2012 ; 76 (5). 1259-1266
39. Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM. Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 ; 157 (4). 251-262
40. Hou FF, Zhou QG. Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection. Nephrology (Carlton). 2010 ; 15 (2). 57-60
41. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998 ; 339 (12). 799-805
42. Hansen T, Ahlström H, Wikström J, Lind L, Johansson L. A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors. Eur Radiol. 2008 ; 18 (6). 1174-1180